TY - JOUR
T1 - Effectiveness of interventions for reducing TB incidence in countries with low TB incidence
T2 - A systematic review of reviews
AU - Collin, Simon M.
AU - Wurie, Fatima
AU - Muzyamba, Morris C.
AU - de Vries, Gerard
AU - Lönnroth, Knut
AU - Migliori, Giovanni Battista
AU - Abubakar, Ibrahim
AU - Anderson, Sarah R.
AU - Zenner, Dominik
PY - 2019/1/1
Y1 - 2019/1/1
N2 - Aims: What is the evidence base for the effectiveness of interventions to reduce tuberculosis (TB) incidence in countries which have low TB incidence? Methods: We conducted a systematic review of interventions for TB control and prevention relevant to low TB incidence settings (<10 cases per 100 000 population). Our analysis was stratified according to “direct” or “indirect” effects on TB incidence. Review quality was assessed using AMSTAR2 criteria. We summarised the strength of review level evidence for interventions as “sufficient”, “tentative”, “insufficient” or “no” using a framework based on the consistency of evidence within and between reviews. Results: We found sufficient review level evidence for direct effects on TB incidence/case prevention of vaccination and treatment of latent TB infection. We also found sufficient evidence of beneficial indirect effects attributable to drug susceptibility testing and adverse indirect effects (measured as sub-optimal treatment outcomes) in relation to use of standardised first-line drug regimens for isoniazid-resistant TB and intermittent dosing regimens. We found insufficient review level evidence for direct or indirect effects of interventions in other areas, including screening, adherence, multidrug-resistant TB, and healthcare-associated infection. Discussion: Our review has shown a need for stronger evidence to support expert opinion and country experience when formulating TB control policy.
AB - Aims: What is the evidence base for the effectiveness of interventions to reduce tuberculosis (TB) incidence in countries which have low TB incidence? Methods: We conducted a systematic review of interventions for TB control and prevention relevant to low TB incidence settings (<10 cases per 100 000 population). Our analysis was stratified according to “direct” or “indirect” effects on TB incidence. Review quality was assessed using AMSTAR2 criteria. We summarised the strength of review level evidence for interventions as “sufficient”, “tentative”, “insufficient” or “no” using a framework based on the consistency of evidence within and between reviews. Results: We found sufficient review level evidence for direct effects on TB incidence/case prevention of vaccination and treatment of latent TB infection. We also found sufficient evidence of beneficial indirect effects attributable to drug susceptibility testing and adverse indirect effects (measured as sub-optimal treatment outcomes) in relation to use of standardised first-line drug regimens for isoniazid-resistant TB and intermittent dosing regimens. We found insufficient review level evidence for direct or indirect effects of interventions in other areas, including screening, adherence, multidrug-resistant TB, and healthcare-associated infection. Discussion: Our review has shown a need for stronger evidence to support expert opinion and country experience when formulating TB control policy.
UR - http://www.scopus.com/inward/record.url?scp=85067290108&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067290108&partnerID=8YFLogxK
U2 - 10.1183/16000617.0107-2018
DO - 10.1183/16000617.0107-2018
M3 - Review article
C2 - 31142548
AN - SCOPUS:85067290108
SN - 0905-9180
VL - 28
JO - European Respiratory Review
JF - European Respiratory Review
IS - 152
M1 - 180107
ER -